David Rosenbaum - Aug 31, 2022 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Aug 31, 2022
Transactions value $
-$904
Form type
4
Date filed
9/1/2022, 07:04 PM
Previous filing
Aug 24, 2022
Next filing
Nov 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Purchase $1.86K +3K +3.36% $0.62* 92.4K Aug 31, 2022 By Wife F1, F2
transaction ARDX Common Stock Sale -$2.76K -3K -3.25% $0.92* 89.4K Sep 1, 2022 By Wife F2
holding ARDX Common Stock 77.6K Aug 31, 2022 Family Trust F3
holding ARDX Common Stock 302K Aug 31, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.